Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters appied:
Tag
close icon
Sort by
SHOCK INDEX IN THE EARLY ASSESSMENT OF FEBRILE CHILDREN AT THE EMERGENCY
Hagedoorn NN, Zachariasse JM, Borensztajn D, Adriaansens E, von Both U, Carrol ED, Eleftheriou I, Emonts M, van der Flier M, de Groot R, Herberg JA, Kohlmaier B, Lim E, Maconochie I, Martinón-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Tsolia M, Zavadska D, Zenz W, Levin M, Vermont C, Moll HA; PERFORM consortium
Journal:
Arch Dis Child
Publicación independiente
Impact factor
3.801
Q1
Year:
2022
Doi:
https://doi.org/10.1136/archdischild-2020-320992
NIRSEVIMAB FOR PREVENTION OF RSV IN HEALTHY LATE-PRETERM AND TERM INFANTS
Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, Muller WJ, Zar HJ, Brooks D, Grenham A, Wählby Hamrén U, Mankad VS, Ren P, Takas T, Abram ME, Leach A, Griffin MP, Villafana T; MELODY Study Group (Martinón-Torres F)
Journal:
N Engl J Med
Publicación independiente
Impact factor
91.253
Q1
Year:
2022
Doi:
VESICULOBULLOUS SKIN REACTIONS INDUCED BY COVID-19 MRNA VACCINE: REPORT OF FOUR CASES AND REVIEW OF THE LITERATURE
Coto-Segura P, Fernández-Prada M, Mir-Bonafé M, García-García B, González-Iglesias I, Alonso-Penanes P, González-Guerrero M, Gutiérrez-Palacios A, Miranda-Martínez E, Martinón-Torres F
Journal:
Clin Exp Dermatol
Publicación independiente
Impact factor
3.470
Q2
Year:
2022
Doi:
https://doi.org/10.1111/ced.14835
EVALUATION OF THE BNT162B2 COVID-19 VACCINE IN CHILDREN 5 TO 11 YEARS OF AGE
Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, Barnett ED, Muñoz FM, Maldonado Y, Pahud BA, Domachowske JB, Simões EAF, Sarwar UN, Kitchin N, Cunliffe L, Rojo P, Kuchar E, Rämet M, Munjal I, Perez JL, Frenck RW Jr, Lagkadinou E, Swanson KA, Ma H, Xu X, Koury K, Mather S, Belanger TJ, Cooper D, Türeci Ö, Dormitzer PR, Şahin U, Jansen KU, Gruber WC; C4591007 Clinical Trial Group. (Martinón-Torres F)
Journal:
N Engl J Med
Publicación independiente
Impact factor
91.253
Q1
Year:
2022
Doi:
CORRIGENDUM: CASE REPORT: TWO MONOCHORIONIC TWINS WITH A CRITICALLY DIFFERENT COURSE OF PROGRESSIVE OSSEOUS HETEROPLASIA
Justicia-Grande AJ, Gómez-Ríal J, Rivero-Calle I, Pischedda S, Curras-Tuala MJ, Gómez-Carballa A, Cebey-López M, Pardo-Seco J, Méndez-Gallart R, Fernández-Seara MJ, Salas A, Martinón-Torres F
Journal:
Front Pediatr
Publicación independiente
Impact factor
3.418
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fped.2021.807812
EARLY IMPACT OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ON PEDIATRIC CLINICAL RESEARCH: A PAN-EUROPEAN AND CANADIAN SNAPSHOT IN TIME.
Mantha OL, Flamein F, Turner MA, Fernandes RM, Hankard R; Network of National Networks Study Group. (Martinón-Torres F)
Journal:
J Pediatr
Publicación independiente
Impact factor
4.406
Q1
Year:
2021
Doi:
DETECTABLE A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS-1 IN SERUM IS ASSOCIATED WITH ADVERSE OUTCOME IN PEDIATRIC SEPSIS
Boeddha NP, Driessen GJ, Hagedoorn NN, Kohlfuerst DS, Hoggart CJ, van Rijswijk AL, Ekinci E, Priem D, Schlapbach LJ, Herberg JA, de Groot R, Anderson ST, Fink CG, Carrol ED, van der Flier M, Martinón-Torres F, Levin M, Leebeek FW, Zenz W, de Maat MPM, Hazelzet JA, Emonts M, Dik WA.
Journal:
Crit Care Explor
Publicación independiente
Impact factor
9.907
Q1
Year:
2021
Doi:
https://doi.org/10.1097/CCE.0000000000000569
EDITORIAL: VACCINATION OF SPECIAL POPULATIONS: PROTECTING THE VULNERABLE.
O'Connor D, Moschese V, Martinon-Torres F, Palma P.
Journal:
Front Immunol
Publicación independiente
Impact factor
7.561
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fimmu.2021.815550
WORLD HEALTH ORGANIZATION INFLUENZA-LIKE ILLNESS UNDERESTIMATES THE BURDEN OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN COMMUNITY-DWELLING OLDER ADULTS.
Korsten K, Adriaenssens N, Coenen S, Butler CC, Verheij TJM, Bont LJ, Wildenbeest JG; RESCEU Investigators.(Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
TIPICO XI: REPORT OF THE FIRST SERIES AND PODCAST ON INFECTIOUS DISEASES AND VACCINES (ATIPICO)
Martinón-Torres F, García-Sastre A, Pollard AJ, Martín C, Osterhaus A, Ladhani SN, Ramilo O, Gómez Rial J, Salas A, Bosch FX, Martinón-Torres M, Mina MJ, Cherry J
Journal:
Hum Vaccin Immunother
Publicación independiente
Impact factor
3.452
Q2
Year:
2021
Doi:
https://doi.org/10.1080/21645515.2021.1953351
SUPPORTING NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUPS IN THE WHO EUROPEAN REGION IN DEVELOPING NATIONAL COVID-19 VACCINATION RECOMMENDATIONS THROUGH ONLINE COMMUNICATION PLATFORM
Mosina L, Külper-Schiek W, Jacques-Carroll L, Earnshaw A, Harder T, Martinón-Torres F, Wilder-Smith A, Wichmann O, Datta SS
Journal:
Vaccine
Publicación independiente
Impact factor
3.641
Q3
Year:
2021
Doi:
https://doi.org/10.1016/j.vaccine.2021.09.034
EXPLORATORY ANALYSIS OF THE ECONOMICALLY JUSTIFIABLE PRICE OF A HYPOTHETICAL RSV VACCINE FOR OLDER ADULTS IN THE NETHERLANDS AND THE UNITED KINGDOM
Zeevat F, Luttjeboer J, Paulissen JHJ, van der Schans J, Beutels P, Boersma C, Postma MJ; RESCEU Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
A SYSTEMATIC REVIEW AND META-ANALYSIS OF ANIMAL STUDIES INVESTIGATING THE RELATIONSHIP BETWEEN SERUM ANTIBODY, T LYMPHOCYTES, AND RESPIRATORY SYNCYTIAL VIRUS DISEASE
McGinley J, Thwaites R, Brebner W, Greenan-Barrett L, Aerssens J, Öner D, Bont L, Wildenbeest J, Martinón-Torres F, Nair H, Pollard AJ, Openshaw P, Drysdale S; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
https://doi.org/10.1093/infdis/jiab370
PUBLISHER CORRECTION: DISTINCT PATTERNS OF WITHIN-HOST VIRUS POPULATIONS BETWEEN TWO SUBGROUPS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS
Lin GL, Drysdale SB, Snape MD, O'Connor D, Brown A, MacIntyre-Cockett G, Mellado-Gomez E, de Cesare M, Bonsall D, Ansari MA, Öner D, Aerssens J, Butler C, Bont L, Openshaw P, Martinón-Torres F, Nair H, Bowden R; RESCEU Investigators, Golubchik T, Pollard AJ
Journal:
Nat Commun
Publicación independiente
Impact factor
14.919
Q1
Year:
2021
Doi:
https://doi.org/10.1038/s41467-021-26291-y
DISEASE BURDEN ESTIMATES OF RESPIRATORY SYNCYTIAL VIRUS RELATED ACUTE RESPIRATORY INFECTIONS IN ADULTS WITH COMORBIDITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
Shi T, Vennard S, Jasiewicz F, Brogden R, Nair H; RESCEU Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
SUPERSPREADING IN THE EMERGENCE OF COVID-19 VARIANTS
Gómez-Carballa A, Pardo-Seco J, Bello X, Martinón-Torres F, Salas A
Journal:
Trends Genet
Publicación independiente
Impact factor
11.639
Q1
Year:
2021
Doi:
https://doi.org/10.1016/j.tig.2021.09.003
A NOVEL VACCINE TO PREVENT MENINGOCOCCAL DISEASE BEYOND THE FIRST YEAR OF LIFE: AN EARLY REVIEW OF MENACYW-TT
Martinón-Torres F, Bertrand-Gerentes I, Oster P
Journal:
Expert Rev Vaccines
Publicación independiente
Impact factor
5.217
Q2
Year:
2021
Doi:
https://doi.org/10.1080/14760584.2021.1964962
A NICE COMBINATION FOR PREDICTING HOSPITALISATION AT THE EMERGENCY DEPARTMENT: A EUROPEAN MULTICENTRE OBSERVATIONAL STUDY OF FEBRILE CHILDREN
Borensztajn DM, Hagedoorn NN, Carrol ED, von Both U, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Lim E, Maconochie IK, Martinon-Torres F, Nieboer D, Nijman RG, Oostenbrink R, Pokorn M, Calle IR, Strle F, Tsolia M, Vermont CL, Yeung S, Zavadska D, Zenz W, Levin M, Moll HA; PERFORM consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union
Journal:
Lancet Reg Health Eur
Publicación independiente
Impact factor
19.173
Q1
Year:
2021
Doi:
https://doi.org/10.1016/j.lanepe.2021.100173
SENSOGENOMICS AND THE BIOLOGICAL BACKGROUND UNDERLYING MUSICAL STIMULI: PERSPECTIVES FOR A NEW ERA OF MUSICAL RESEARCH
Navarro L, Martinón-Torres F, Salas A
Journal:
Genes (Basel)
Publicación independiente
Impact factor
4.096
Q2
Year:
2021
Doi:
https://doi.org/10.3390/genes12091454
DISTINCT PATTERNS OF WITHIN-HOST VIRUS POPULATIONS BETWEEN TWO SUBGROUPS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS
Lin GL, Drysdale SB, Snape MD, O'Connor D, Brown A, MacIntyre-Cockett G, Mellado-Gomez E, de Cesare M, Bonsall D, Ansari MA, Öner D, Aerssens J, Butler C, Bont L, Openshaw P, Martinón-Torres F, Nair H, Bowden R; RESCEU Investigators, Golubchik T, Pollard AJ
Journal:
Nat Commun
Publicación independiente
Impact factor
14.919
Q1
Year:
2021
Doi:
https://doi.org/10.1038/s41467-021-25265-4
COADMINISTRATION OF ANTI-VIRAL MONOCLONAL ANTIBODIES WITH ROUTINE PEDIATRIC VACCINES AND IMPLICATIONS FOR NIRSEVIMAB USE: A WHITE PAPER
Esposito S, Abu-Raya B, Bonanni P, Cahn-Sellem F, Flanagan KL, Martinon Torres F, Mejias A, Nadel S, Safadi MAP, Simon A
Journal:
Front Immunol
Publicación independiente
Impact factor
7.561
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fimmu.2021.708939
AETIOLOGY OF ACUTE RESPIRATORY INFECTION IN PRESCHOOL CHILDREN REQUIRING HOSPITALISATION IN EUROPE-RESULTS FROM THE PED-MERMAIDS MULTICENTRE CASE-CONTROL STUDY
Kohns Vasconcelos M, Loens K, Sigfrid L, Iosifidis E, Epalza C, Donà D, Matheeussen V, Papachristou S, Roilides E, Gijon M, Rojo P, Minotti C, Da Dalt L, Islam S, Jarvis J, Syggelou A, Tsolia M, Nyirenda Nyang'wa M, Keers S, Renk H, Gemmel AL, D'Amore C, Ciofi Degli Atti M, Rodríguez-Tenreiro Sánchez C, Martinón-Torres F, Burokienė S, Goetghebuer T, Spoulou V, Riordan A, Calvo C, Gkentzi D, Hufnagel M, Openshaw PJ, de Jong MD, Koopmans M, Goossens H, Ieven M, Fraaij PLA, Giaquinto C, Bielicki JA, Horby P, Sharland M.
Journal:
BMJ Open Respir Res
Publicación independiente
Impact factor
2.692
Q2
Year:
2021
Doi:
https://doi.org/10.1136/bmjresp-2021-000887
A NOVEL FRAMEWORK FOR PHENOTYPING CHILDREN WITH SUSPECTED OR CONFIRMED INFECTION FOR FUTURE BIOMARKER STUDIES
Nijman RG, Oostenbrink R, Moll HA, Casals-Pascual C, von Both U, Cunnington A, De T, Eleftheriou I, Emonts M, Fink C, van der Flier M, de Groot R, Kaforou M, Kohlmaier B, Kuijpers TW, Lim E, Maconochie IK, Paulus S, Martinon-Torres F, Pokorn M, Romaine ST, Calle IR, Schlapbach LJ, Smit FJ, Tsolia M, Usuf E, Wright VJ, Yeung S, Zavadska D, Zenz W, Levin M, Herberg JA, Carrol ED; PERFORM consortium (Personalized Risk assessment in febrile children to optimize Real-life Management across the European Union).
Journal:
Front Pediatr
Publicación independiente
Impact factor
3.418
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fped.2021.688272
EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF M-M-RII (COMBINATION MEASLES-MUMPS-RUBELLA VACCINE): CLINICAL TRIALS OF HEALTHY CHILDREN AND ADULTS PUBLISHED BETWEEN 2010 AND 2019
Nyaku M, Richardson E, Martinon-Torres F, Kuter BJ
Journal:
Pediatr Infect Dis J
Publicación independiente
Impact factor
2.129
Q3
Year:
2021
Doi:
https://doi.org/10.1097/INF.0000000000003273
No results found.
¿Dónde se esconde el virus respiratorio sincitial?
Martinón-Torres F, González-Barcala FJ
Doi:
Arch Bronconeumol
Factor de impacto:
Q2
Doi:
YEAR-TO-YEAR VARIATION IN ATTACK RATES COULD RESULT IN UNDERPOWERED RESPIRATORY SYNCYTIAL VIRUS VACCINE EFFICACY TRIALS
Billard MN, Wildenbeest J, Bont LJ, Nair H, McCracken JP, Oude Rengerink K; RESCEU Investigators (Martinón-Torres F)
Doi:
J Clin Epidemiol
Factor de impacto:
Q1
Doi:
COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE PREVENTION STRATEGIES: MATERNAL VACCINE VERSUS SEASONAL OR YEAR-ROUND MONOCLONAL ANTIBODY PROGRAM IN NORWEGIAN CHILDREN
Li X, Bilcke J, Vázquez Fernández L, Bont L, Willem L, Wisløff T, Jit M, Beutels P; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators. (martinón-Torres F)
Doi:
J Infect Dis
Factor de impacto:
Q1
Doi:
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II TRIAL TO EXPLORE THE EFFECTS OF A GABAA-Α5 NAM (BASMISANIL) ON INTELLECTUAL DISABILITY ASSOCIATED WITH DOWN SYNDROME
Goeldner C, Kishnani PS, Skotko BG, Casero JL, Hipp JF, Derks M, Hernandez MC, Khwaja O, Lennon-Chrimes S, Noeldeke J, Pellicer S, Squassante L, Visootsak J, Wandel C, Fontoura P, d'Ardhuy XL; Clematis Study Group (Martinón-Torres F)
Doi:
J Neurodev Disord
Factor de impacto:
Q2
Doi:
PERFORMANCE ASSESSMENT OF A RAPID MOLECULAR RESPIRATORY SYNCYTIAL VIRUS POINT-OF-CARE TEST: A PROSPECTIVE COMMUNITY STUDY IN OLDER ADULTS
Zuurbier RP, Korsten K, Verheij TJM, Butler C, Adriaenssens N, Coenen S, Gruselle O, Vantomme V, van Houten MA, Bont LJ, Wildenbeest JG; REspiratory Syncytial Virus Consortium in EUrope (RESCEU) Investigators. (Martinón-Torres F)
Doi:
J Infect Dis
Factor de impacto:
Q1
Doi:
RAPID VIRAL TESTING AND ANTIBIOTIC PRESCRIPTION IN FEBRILE CHILDREN WITH RESPIRATORY SYMPTOMS VISITING EMERGENCY DEPARTMENTS IN EUROPE
Tan CD, Hagedoorn NN, Dewez JE, Borensztajn DM, von Both U, Carrol ED, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Strle F, Tsolia M, Vermont CL, Yeung S, Zachariasse JM, Zenz W, Zavadska D, Moll HA; PERFORM Consortium
Doi:
Pediatr Infect Dis J
Factor de impacto:
Q4
Doi:
Pediatric vaccination against COVID-19 and despite COVID-19
Martinón-Torres F
Doi:
An Pediatr (Engl Ed)
Factor de impacto:
Q4
Doi:
A SYSTEMATIC REVIEW OF EUROPEAN CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS
Reeves RM, van Wijhe M, Lehtonen T, Stona L, Teirlinck AC, Vazquez Fernandez L, Li Y, Osei-Yeboah R, Fischer TK, Heikkinen T, van Boven M, Bøås H, Donà D, Barbieri E, Campbell H; RESCEU Investigators. (Martinón-Torres F)
Doi:
J Infect Dis
Factor de impacto:
Q1
Doi:
EQUITY IN VACCINATION POLICIES TO OVERCOME SOCIAL DEPRIVATION AS A RISK FACTOR FOR INVASIVE MENINGOCOCCAL DISEASE.
Taha MK, Martinon-Torres F, Köllges R, Bonanni P, Safadi MAP, Booy R, Smith V, Garcia S, Bekkat-Berkani R, Abitbol V
Doi:
Expert Rev Vaccines
Factor de impacto:
Q2
Doi:
COVIDPHY: A TOOL FOR PHYLOGEOGRAPHIC ANALYSIS OF SARS-COV-2 VARIATION
Bello X, Pardo-Seco J, Gómez-Carballa A, Weissensteiner H, Martinón-Torres F, Salas A
Doi:
Environ Res
Factor de impacto:
Q1
Doi:
ROUTINE INFANT VACCINATION OF PNEUMOCOCCAL CONJUGATE VACCINES HAS DECREASED PNEUMONIA ACROSS ALL AGE GROUPS IN NORTHERN SPAIN
I. Rivero-Calle, J. Pardo Seco, P. F. Raguindin, F. Alvez, J. Gómez-Rial, A. Salas, J. Martinón Sanchez and F. Martinón-Torres
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
QUADRIVALENT INFLUENZA VACCINE PREVENTS ILLNESS AND REDUCES HEALTHCARE UTILIZATION ACROSS DIVERSE GEOGRAPHIC REGIONS DURING FIVE INFLUENZA SEASONS. A RANDOMIZED CLINICAL TRIAL
Ghassan Dbaibo, Arshad Amanullah, Carine Claeys, Allen Izu, Varsha K. Jain, Pope Kosalaraksa, Luis Rivera, Jyoti Soni, Emad Yanni, Khalequ Zaman, Beatriz Acosta, Miguel Ariza, Maria L. Arroba Basanta, Ashish Bavdekar, Alfonso Carmona, Luis Cousin, Jasur Danier, Alfonso Diaz, Javier Diez-Domingo, Ener C. Dinleyici, Saul N. Faust, Jose Garcia-Sicilia, Grace D. Gomez-Go, Maria L. A. Gonzales, Mustafa Hacimustafaoglu, Stephen M. Hughes, Teresa Jackowska, Shashi Kant, Marilla Lucero, Josep Mares Bermudez, Federico Martinón-Torres, May Montellano, Roman Prymula, Thanyawee Puthanakit, Renata Ruzkova, Iwona Sadowska-Krawczenko Henryk Szymanski, Angels Ulied, Wayne Woo, Anne Schuind and Bruce L. Innis for the Flu4VEC Study Group
Pediatr Infect Dis J
Factor de impacto:
Doi:
Links
Department of pediatricsGenCovidNanostringNextSeq
Legal noticePrivacy policy
Genvip 2023® – All rights reserved